2μg ( R: reducing condition, N: non-reducing condition).
Product Details
Product Details
Product Specification
Species | Human |
Antigen | MIF |
Synonyms | rHuMMIF, GLIF, MMIF, MIF |
Accession | P14174 |
Amino Acid Sequence | Pro2-Ala115 |
Expression System | E.coli |
Molecular Weight | 12.5kDa |
Purity | >95% by SDS-PAGE&RP-HPLC |
Endotoxin | <0.1EU/μg |
Conjugation | Unconjugated |
Tag | No Tag |
Physical Appearance | Lyophilized Powder |
Storage Buffer | 20mM PB, 100mM NaCl, pH6.0 |
Reconstitution | Reconstitute at 0.1-1 mg/ml according to the size in ultrapure water after rapid centrifugation. |
Stability & Storage |
· 12 months from date of receipt, lyophilized powder stored at -20 to -80℃. · 3 months, -20 to -80℃ under sterile conditions after reconstitution. · 1 week, 2 to 8℃ under sterile conditions after reconstitution. · Please avoid repeated freeze-thaw cycles. |
Reference | 1. Nat Rev Immunol. 2003 Oct;3(10):791-800. |
Background
Macrophage migration inhibitory factor (MIF) has been a mysterious cytokine. MIF has assumed an important role as a pivotal regulator of innate immunity. In the pathogenesis of sepsis, and inflammatory and autoimmune diseases, suggesting that MIF-directed therapies might offer new treatment opportunities for human diseases in the future.
Picture
Picture
SDS-PAGE

RP-HPLC


